Atom Investors LP Ironwood Pharmaceuticals Inc Call Options Transaction History

Atom Investors LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $451,999 - $593,000	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $31,675 - $42,700	-3,500 Reduced 6.54%	50,000 $570,000
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $488,990 - $640,395	53,500 New	53,500 $552,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.